Performance of claims-based Alzheimer’s disease and related dementias algorithms in Medicare Advantage and fee-for-service populations
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 06.10.2026 · 81 (11)
DOI: 10.1093/gerona/glag237 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 18.09.2026. Verfasst von You Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusett, United States. Hauptthemen laut MEDLINE: Fee-for-Service Plans, Medicare Part C, Algorithms, Alzheimer Disease. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIH HHS, National Institutes of Health.
Themen: Demenz
Abstract (Originalsprache)
Background
Evidence comparing the performance of claims-based dementia algorithms across Medicare Advantage (MA) and fee-for-service (FFS) populations remains limited. We evaluated the validity of 2 claims-based algorithms across MA and FFS populations.
Methods
We used nationally representative, linked National Health and Aging Trends Study (NHATS)-Medicare data to identify community-dwelling participants with continuous enrollment in MA or FFS during Round 7 (2017; n = 5018), Round 9 (2019; n = 4018), and Round 11 (2021-2022; n = 3086). Using NHATS probable dementia as reference standard, we validated the Bynum-Standard and Chronic Condition Warehouse (CCW) dementia algorithms across 3-time points.
Results
Overall, both algorithms demonstrated comparable performance in MA and FFS populations, with high specificity (>97.9%) and negative predictive value (>92.9%). The Bynum algorithm showed similar sensitivity between MA and FFS in Rounds 7 (30.2% vs 29.1%) and 11 (25.6% vs 23.9%), but lower sensitivity in MA for Round 9 (25.0% vs 36.4%). Positive predictive value (PPV) was similar between MA (62.7%-70.6%) and FFS (62.1%-70.4%) across all rounds. The CCW algorithm demonstrated greater MA-FFS differences, with lower sensitivity in MA for Rounds 9 (30.8% vs 46.9%) and 11 (35.0% vs 49.3%) and similar sensitivity for Round 7 (40.4% vs 42.2%). PPV varied across rounds in both MA and FFS ([Round 7: 76.3% vs 71.2%] to [Round 11: 68.5% vs 76.4%]). Both algorithms identified participants with more severe dementia.
Conclusion
Claims-based dementia algorithms demonstrate broadly consistent performance in MA and FFS populations, with high specificity and moderate PPV but comparable or lower sensitivity in MA, informing case ascertainment across Medicare plan type.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusett, United States.
- Division of Gerontology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusett, United States.
ORCID-Profile: Chan Mi Park, Lan Luo, Sandra M Shi, Dae Hyun Kim, Ellen P McCarthy
Förderung
- NIA NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Wu, Y., Park, C. M., Chen, X., Luo, L., Kim, E. G., Shi, S. M., Kim, D. H., & McCarthy, E. P. (2026). Performance of claims-based Alzheimer’s disease and related dementias algorithms in Medicare Advantage and fee-for-service populations. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 81(11). https://doi.org/10.1093/gerona/glag237
Vancouver
Wu Y, Park CM, Chen X, Luo L, Kim EG, Shi SM, et al. Performance of claims-based Alzheimer’s disease and related dementias algorithms in Medicare Advantage and fee-for-service populations. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2026;81(11). doi:10.1093/gerona/glag237
BibTeX
@article{Wu2026,
author = {Wu, You and Park, Chan Mi and Chen, Xiecheng and Luo, Lan and Kim, Eunji G and Shi, Sandra M and Kim, Dae Hyun and McCarthy, Ellen P},
title = {Performance of claims-based Alzheimer’s disease and related dementias algorithms in Medicare Advantage and fee-for-service populations},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2026},
volume = {81},
number = {11},
doi = {10.1093/gerona/glag237}
}
EUVIMED